Interpreting SPRINT: How low should you go?

Area of Science:

• Cardiology
• Clinical Trials
• Hypertension Management

Background:

• Current hypertension guidelines recommend a systolic blood pressure goal of < 140 mm Hg.
• Older adults with cardiovascular risk factors face increased risk of adverse events.
• Previous trials have not definitively established the optimal systolic blood pressure target for this population.

Purpose of the Study:

• To evaluate the cardiovascular benefits of an intensive systolic blood pressure target (< 120 mm Hg) versus a standard target (< 140 mm Hg).
• To assess the impact of intensive blood pressure management on cardiovascular outcomes in high-risk older adults without diabetes or stroke.

Main Methods:

• The Systolic Blood Pressure Intervention Trial (SPRINT) was a randomized controlled trial.
• Participants were older adults with elevated cardiovascular risk but no history of diabetes or stroke.
• Intervention involved intensive blood pressure management aiming for < 120 mm Hg versus standard management aiming for < 140 mm Hg.

Main Results:

• Intensive systolic blood pressure lowering demonstrated a significant reduction in cardiovascular events.
• The trial provided robust evidence supporting a lower blood pressure target for cardiovascular risk reduction.
• Specific benefits included reduced rates of heart attack, stroke, and cardiovascular death.

Conclusions:

• An intensive systolic blood pressure goal of < 120 mm Hg is associated with significant cardiovascular benefits in high-risk older adults.
• These findings challenge existing hypertension management guidelines and suggest a need for revised treatment targets.
• The SPRINT trial has major implications for clinical practice and public health in hypertension management.